CLINICAL_TRIALS
trial_result
· 2018-03-27
Clinical Trial Update: Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Summary
Phase 2 trial update investigating lenalidomide as an immune adjuvant in patients with chronic lymphocytic leukemia (CLL); trial status terminated with results …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Hematologic Disorder | Phase 2 | Status: TERMINATED | Results posted: 2018-03-27